All In MedTech

Device Trial Radar · NCT05547984

Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)

A Randomized Controlled Trial Comparing Modular Dual Mobility Inserts With Ceramic Multilayer Coating Versus Standard Polyethylene Inserts for Primary Total Hip Arthroplasty (THA) in a Cementless Acetabular Cup

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Nov 21, 2022

Primary completion

Sep 2027

Study completion Aug 2028

Sponsor

Lead sponsor
Aesculap AGNot on our public-company list
Sponsor type
Industry
First posted
Sep 21, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup

Conditions

  • Coxarthrosis; Primary

Interventions

  • Dual Mobility CupDevice

    Total hip arthroplasty (THA) is a successful and established therapy for coxarthrosis, rheumatic arthritis, hip fractures and femoral head necrosis. The acetabular implant for this arm is the Dual Mobility cup

  • Standard Acetabular componentDevice

    Total hip arthroplasty (THA) is a successful and established therapy for coxarthrosis, rheumatic arthritis, hip fractures and femoral head necrosis. The acetabular implant for this arm is the standard device with polyethylene + vitamin E inlay and metal head

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serum metal ion analysis (Cobalt)Time frame: 12 months after surgery
  2. Serum metal ion analysis (Chromium)Time frame: 12 months after surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Masaryk Hospital

    Ústí nad Labem, Czechia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.